275 related articles for article (PubMed ID: 16696648)
1. Towards a vaccine for Cryptococcus neoformans: principles and caveats.
Datta K; Pirofski LA
FEMS Yeast Res; 2006 Jun; 6(4):525-36. PubMed ID: 16696648
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain.
Wormley FL; Cox GM; Perfect JR
Microb Pathog; 2005; 38(2-3):113-23. PubMed ID: 15748813
[TBL] [Abstract][Full Text] [Related]
3. Anti-glucuronoxylomannan IgG1 specific antibodies production in Cryptococcus neoformans resistant mice.
Parra C; González JM; Castañeda E; Fiorentino S
Biomedica; 2005 Mar; 25(1):110-9. PubMed ID: 15962907
[TBL] [Abstract][Full Text] [Related]
4. Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants.
Zhai B; Wozniak KL; Masso-Silva J; Upadhyay S; Hole C; Rivera A; Wormley FL; Lin X
mBio; 2015 Oct; 6(5):e01433-15. PubMed ID: 26443458
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with Recombinant
Specht CA; Lee CK; Huang H; Hester MM; Liu J; Luckie BA; Torres Santana MA; Mirza Z; Khoshkenar P; Abraham A; Shen ZT; Lodge JK; Akalin A; Homan J; Ostroff GR; Levitz SM
mBio; 2017 Nov; 8(6):. PubMed ID: 29184017
[TBL] [Abstract][Full Text] [Related]
6. Innate host defenses against Cryptococcus neoformans.
Hole C; Wormley FL
J Microbiol; 2016 Mar; 54(3):202-11. PubMed ID: 26920880
[TBL] [Abstract][Full Text] [Related]
7. Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting.
Lamura L; Matthews RC; Barchiesi F; Donahoe M; Burnie JP; Scalise G
J Infect; 2000 Jan; 40(1):64-8. PubMed ID: 10762114
[TBL] [Abstract][Full Text] [Related]
8. Immunology of infection caused by Cryptococcus neoformans.
Wormley FL; Perfect JR
Methods Mol Med; 2005; 118():193-8. PubMed ID: 15888944
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and prospects for a vaccine to prevent cryptococcosis.
Casadevall A; Pirofski LA
Med Mycol; 2005 Dec; 43(8):667-80. PubMed ID: 16422296
[TBL] [Abstract][Full Text] [Related]
10. Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans.
Upadhya R; Lam WC; Maybruck B; Specht CA; Levitz SM; Lodge JK
mBio; 2016 May; 7(3):. PubMed ID: 27165801
[TBL] [Abstract][Full Text] [Related]
11. Is Development of a Vaccine against Cryptococcus neoformans Feasible?
Leopold Wager CM; Wormley FL
PLoS Pathog; 2015 Jun; 11(6):e1004843. PubMed ID: 26087178
[No Abstract] [Full Text] [Related]
12. Clinical and serologic evaluation of cats with cryptococcosis.
Flatland B; Greene RT; Lappin MR
J Am Vet Med Assoc; 1996 Sep; 209(6):1110-3. PubMed ID: 8800258
[TBL] [Abstract][Full Text] [Related]
13. A Heat-Killed
Wang Y; Wang K; Masso-Silva JA; Rivera A; Xue C
mBio; 2019 Nov; 10(6):. PubMed ID: 31772051
[No Abstract] [Full Text] [Related]
14. Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens.
Pirofski LA
Trends Microbiol; 2001 Sep; 9(9):445-51. PubMed ID: 11553457
[TBL] [Abstract][Full Text] [Related]
15. Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.
Specht CA; Lee CK; Huang H; Tipper DJ; Shen ZT; Lodge JK; Leszyk J; Ostroff GR; Levitz SM
mBio; 2015 Dec; 6(6):e01905-15. PubMed ID: 26695631
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody to fungal glucosylceramide protects mice against lethal Cryptococcus neoformans infection.
Rodrigues ML; Shi L; Barreto-Bergter E; Nimrichter L; Farias SE; Rodrigues EG; Travassos LR; Nosanchuk JD
Clin Vaccine Immunol; 2007 Oct; 14(10):1372-6. PubMed ID: 17715331
[TBL] [Abstract][Full Text] [Related]
17. Methodology for Anti-Cryptococcal Vaccine Development.
Chaturvedi AK; Wormley FL
Methods Mol Biol; 2017; 1625():129-140. PubMed ID: 28584988
[TBL] [Abstract][Full Text] [Related]
18. Serum antibody response to active infection with Cryptococcus neoformans and its varieties in immunocompetent subjects.
Speed BR; Kaldor J; Cairns B; Pegorer M
J Med Vet Mycol; 1996; 34(3):187-93. PubMed ID: 8803799
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis.
Chow SK; Casadevall A
Vaccine; 2011 Feb; 29(10):1891-8. PubMed ID: 21238568
[TBL] [Abstract][Full Text] [Related]
20. A Call to Arms: Quest for a Cryptococcal Vaccine.
Caballero Van Dyke MC; Wormley FL
Trends Microbiol; 2018 May; 26(5):436-446. PubMed ID: 29103990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
